ARTICLE | Financial News
XTL completes direct public offering
April 6, 2015 7:00 AM UTC
XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB; Tel Aviv:XTL), Herzliya, Israel Business: Cancer, Neurology, Infectious Date completed: 2015-03-31 Type: Direct public offering Raised: $4 million Shares: 1.8...